Psychedelic-Assisted

Psychotherapy

ATMA CENA ~ MEMBER CLINIC

We’re excited to have partnered with ATMA CENA Psychedelic Healthcare Solutions, a National Network of clinics focused on making safe, evidence-based, effective mental healthcare accessible to all Canadians. As an ATMA CENA member clinic, we’re here to support your mental health well-being by offering new, evidence-based therapies like Ketamine-Assisted Therapy, as well as Psilocybin (aka “magic mushrooms”) and MDMA (aka “molly”) assisted therapy through Health Canada’s Special Access Program. These treatments have the incredible potential to address not just the symptoms of a wide range of mental health issues, but the underlying factors contributing to conditions like treatment resistant depression (TRD), anxiety, PTSD, chronic pain, and much more.

Backed by research and guided by compassion, our mental health services offer a new path forward for those seeking relief. We’re here to help you every step of the way. We encourage you to book a free Info Call with us to learn more about these treatments and whether they could be right for you!

Ketamine

Ketamine Assisted Psychotherapy is an innovative and promising mental health treatment option that utilizes ketamine’s unique ability to induce an altered state of consciousness, freeing the mind from ingrained constructs and alleviating pain, allowing individuals to explore and process difficult emotions and memories in a safe and supportive environment.

KaP can help you heal from the bottom up, addressing root causes of mental health challenges. By combining the remarkable properties of ketamine with skilled therapy, you can access thoughts, emotions, and memories that may have felt out of reach in traditional talk therapy, allowing for deeper levels of healing.

Ketamine Assisted Psychotherapy starts at $1499 per treatment plan.

Psilocybin & MDMA

Psilocybin and MDMA Assisted Psychotherapy is an option that can be explored when other modalities such as antidepressants or talk-therapy don’t work and has been used as an adjunct to therapy since the 1970’s.

While the safety and effectiveness of Psilocybin and MDMA in therapy is still under investigation, Health Canada allows physicians to request access for unique cases of treatment-resistant mental health concerns, specifically depression and end-of-life for Psilocybin, and PTSD for MDMA.

Clients can apply to access this unique mental health treatment through a specific application process, even though this treatment has not yet received official approval. (Special Access Program).

Application fee is $850.

Potential Benefits to Ketamine-Assisted Psychotherapy:

Quick symptom relief: Rapid reduction in depression, anxiety and PTSD symptoms.

Effective for resistant cases: Particularly helpful for those unresponsive to traditional treatments.

Enhances therapy: Deepens therapeutic experiences, aiding emotional processing.

Promotes neuroplasticity: Encourages new neural connections, potentially improving long-term mental health.

Boosts mood and well-being: Many clients report enhanced mood and overall well-being post-treatment.

Ketamine “Resets” the brain’s response to stress, opening doors to healing when other treatments have failed.
By fostering new neural pathways, ketamine paves the way for sustainable recovery and a renewed sense of purpose in both personal and professional life; ketamine therapy can be a transformative tool to revitalize your spirit and regain control over your well-being.

Potential Benefits to Psilocybin-Assisted Psychotherapy:

Can reduce depression: Can significantly lower depression symptoms, effective even in treatment-resistant cases.

Alleviates anxiety: Helps decrease anxiety, especially in individuals with life-threatening conditions.

Increases emotional openness: Boosts empathy and emotional openness, aiding in emotional processing and relationship improvements.

Decreased substance dependence: Shows promise in reducing addiction to substances like alcohol and nicotine.

Improves quality of life: Participants report enhanced overall well-being and life satisfaction.

Long-lasting effects: Benefits such as mood improvement can persist for months or years after the sessions.

In therapeutic settings. psilocybin helps to facilitate experiences that promote self-reflection, emotional exploration, and personal growth. Research suggests that psilocybin-assisted therapy may have long-lasting positive effects on mood, well-being, and can cause a renewed sense of meaning and purpose in life.

Potential Benefits to MDMA-
Assisted Psychotherapy:

Enhanced emotional processing: Lowers psychological defences to better process traumatic memories.

Reduced fear and anxiety: Creates a safe space for confronting trauma by reducing anxiety.

Increased empathy and connection: Boosts feelings of empathy and connection, improving therapeutic relationships.

Improved PTSD symptoms: Offers significant symptom reduction for those struggling with PTSD.

Lasting effects from limited sessions: Produces enduring benefits from few treatment sessions.

Potential for treating other conditions: Shows promise for treating a range of mental health issues beyond PTSD.

Studies have shown that MDMA-assisted therapy demonstrates greater therapeutic efficacy than any other therapy or medication for PTSD, with more than two-thirds of clients no longer meeting the criteria for PTSD when measured one year after treatment.

RESOURCES